TP53 and hepatocellular carcinoma: In wild-type p53 hepatocellular carcinoma, p53 disrupts MPC activity by activating transcription of PUMA, a mitochondrial protein that binds to the MPC1 protein and inhibits the oligomerization of MPC1 and MPC2 [51].